 earli ribavirin treatment respiratori syncyti viral infect high-risk children prospect multicent studi efficaci earli ribavirin intervent mild respiratori syncyti viru ill children bronchopulmonari dysplasia congenit heart diseas cohort children month age bronchopulmonari dysplasia congenit heart diseas forty-seven infant respiratori syncyti viru infect mild symptom equal hour durat ribavirin water placebo aerosol hospit home outcom measur respiratori analog score room air oxygen satur oxygen flow satur equal differ age gender famili size passiv smoke baselin oxygen satur room air durat symptom treatment group day therapi ribavirin rate improv analog score equal oxygen requir oxygen satur respiratori score total hospit day group treatment failur children ribavirin group children placebo group nonsignific differ child assist ventil advers reaction earli ribavirin therapi morbid respiratori syncyti viru infect high-risk young children